Press Releases

Press Releases

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK --(BUSINESS WIRE)--Apr. 16, 2021-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today reported that on April 13, 2021 , the company granted non-statutory stock options to purchase an aggregate of
April 16, 2021

Schrödinger Reports Preclinical Data on Novel, Selective CDC7 Inhibitors Presented at American Association for Cancer Research Annual Meeting

– Data highlight continued progress across internal pipeline; Company continues to plan for multiple IND-enabling studies in 2021 and up to three IND applications in 2022 – – Schrödinger to provide an overview of CDC7, MALT1 and Wee1 programs during a webcast today at 10:00 a.m.
April 12, 2021

Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery

NEW YORK --(BUSINESS WIRE)--Apr. 9, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid , Ph.D., chief executive officer at Schrödinger, will participate in a panel during the BMO
April 9, 2021

Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting

NEW YORK --(BUSINESS WIRE)--Mar. 30, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a webcast to review the preclinical data being presented from its CDC7 program during a
March 30, 2021

Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence

NEW YORK --(BUSINESS WIRE)--Mar. 17, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid , Ph.D., chief executive officer at Schrödinger, will participate in a panel during the
March 17, 2021

Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021

NEW YORK --(BUSINESS WIRE)--Mar. 10, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that preclinical data from its CDC7 program will be presented in a virtual poster session at the American
March 10, 2021

Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021

Total revenue of $108.1 million in 2020, up 26 percent year-over-year Software revenue of $92.5 million in 2020, up 39 percent year-over-year Strong financial position enables continued investment in advancing the science underlying Schrödinger’s computational platform Internal pipeline
March 4, 2021

Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference

NEW YORK --(BUSINESS WIRE)--Mar. 1, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a corporate overview during the H.C.
March 1, 2021

Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives

NEW YORK --(BUSINESS WIRE)--Feb. 25, 2021-- Schrödinger, Inc. (Nasdaq: SDGR) today announced it has expanded its collaboration with Google Cloud to further increase the speed and capacity of its physics-based computational platform for drug discovery and materials science.
February 25, 2021

Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference

NEW YORK --(BUSINESS WIRE)--Feb. 19, 2021-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a corporate overview at the SVB Leerink Partners 10 th Annual Global
February 19, 2021
Displaying 11 - 20 of 21
Back To Top